LakeShore Biopharma Co (FRA:H6Z0) Net Margin %: -49.61% (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:H6Z0 LakeShore Biopharma Co Ltd FRA:H6Z0
17 GF Score
Price €0.67
View Full Analysis

What is LakeShore Biopharma Co Net Margin %?

LakeShore Biopharma Co FRA:H6Z0 17 Net Margin % is -49.61% as of Mar. 2025. GuruFocus rates FRA:H6Z0 with a GF Score™ of 17/100.

Net margin is calculated as Net Income divided by its Revenue. LakeShore Biopharma Co's Net Income for the six months ended in Mar. 2025 was €-15.38 Mil. LakeShore Biopharma Co's Revenue for the six months ended in Mar. 2025 was €31.01 Mil. Therefore, LakeShore Biopharma Co's net margin for the quarter that ended in Mar. 2025 was -49.61%.

The historical rank and industry rank for LakeShore Biopharma Co's Net Margin % or its related term are showing as below:


FRA:H6Z0's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -89.56
* Ranked among companies with meaningful Net Margin % only.

LakeShore Biopharma Co  (FRA:H6Z0) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

LakeShore Biopharma Co Net Margin % Related Terms

LakeShore Biopharma Co Net Margin % Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Net Margin % Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Net Margin %
-74.63 -21.08 -21.17 -75.59 -16.26

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Net Margin % Get a 7-Day Free Trial Premium Member Only -46.70 -63.91 -86.22 5.53 -49.61

FRA:H6Z0 vs ACUT, PPCB, ENSC: Net Margin % Comparison

For the Biotechnology subindustry, LakeShore Biopharma Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LakeShore Biopharma Co Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LakeShore Biopharma Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where LakeShore Biopharma Co's Net Margin % falls into.


FRA:H6Z0
17GF Score
LakeShore Biopharma Co Ltd FRA:H6Z0
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LakeShore Biopharma Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

LakeShore Biopharma Co's Net Margin for the fiscal year that ended in Mar. 2025 is calculated as

Net Margin=Net Income (A: Mar. 2025 )/Revenue (A: Mar. 2025 )
=-12.758/78.468
=-16.26 %

LakeShore Biopharma Co's Net Margin for the quarter that ended in Mar. 2025 is calculated as

Net Margin=Net Income (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=-15.383/31.009
=-49.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -49.61% mean?
LakeShore Biopharma Co (FRA:H6Z0) has a Net Margin % of -49.61% as of Mar. 2025. Net margin is the ratio of total net income to net sales. View historical data on LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Net Margin % too high?
LakeShore Biopharma Co's current Net Margin % is -49.61%. Overall, LakeShore Biopharma Co has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does LakeShore Biopharma Co's Net Margin % compare to ACUT and PPCB?
LakeShore Biopharma Co's Net Margin % of -49.61% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Net Margin % is -49.61%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (FRA:H6Z0) has a current Net Margin % of -49.61%. The current Net Margin % is -49.61%. LakeShore Biopharma Co's overall GF Score™ is 17/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For LakeShore Biopharma Co (FRA:H6Z0), the current Net Margin % is -49.61% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Other Exchanges LSBCF:USA
Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.
17GF Score

Get the complete analysis for FRA:H6Z0

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.67
Price